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The functional analysis of sequenced genomes will be facilitated by the development of tools for the rapid
mapping of mutations. We have developed a systematic approach to genetic mapping in Caulobacter crescentus
that is based on bacteriophage-mediated transduction of strategically placed antibiotic resistance markers.
The genomic DNA sequence was used to identify sites distributed evenly around the chromosome at which
plasmids could be nondisruptively integrated. DNA fragments from these sites were amplified by PCR and
cloned into a kanamycin-resistant (Kanr) suicide vector. Delivery of these plasmids into C. crescentus resulted
in integration via homologous recombination. A set of 41 strains containing Kanr markers at 100-kb intervals
was thereby generated. These strains serve as donors for generalized transduction using bacteriophage Cr30,
which can transduce at least 120 kb of DNA. Transductants are selected with kanamycin and screened for loss
of the mutant phenotype to assess linkage between the marker and the site of the mutation. The dependence
of cotransduction frequency on sequence distance was evaluated using several markers and mutant strains.
With these data as a standard, previously unmapped mutations were readily localized to DNA sequence
intervals equivalent to less than 1% of the genome. Candidate genes within the interval were then examined
further by subcloning and complementation analysis. Mutations resulting in sensitivity to ampicillin, in
nutritional auxotrophies, or temperature-sensitive growth were mapped. This approach to genetic mapping
should be applicable to other bacteria with sequenced genomes for which generalized transducing phage are
available.
Complete genomic DNA sequences have generated fascinat-
ing insights into the biology and evolutionary history of many
bacterial species. Genome sequences have also enabled pow-
erful new technologies such as microarrays to be applied to
understanding the activities of microorganisms (25). Some-
times overlooked is the fact that genomic sequence informa-
tion can be very productively combined with traditional meth-
ods of genetic analysis. We have used the recently completed
Caulobacter crescentus genome sequence (17) as a guide to
produce a set of genetic mapping strains suitable as donors for
generalized transduction. Using these mapping strains, muta-
tions with a variety of phenotypes can be quickly and reliably
localized to a small fraction of the genome, identifying candi-
date genes for further investigation. This technique will signif-
icantly speed up genetic analysis of C. crescentus and is likely to
be applicable to other bacterial species as well.
C. crescentus is a gram-negative aquatic bacterium that
serves as a model system for studying the bacterial cell cycle
and development (19). Caulobacter exhibits two distinct ap-
pendaged cell types—a motile swarmer cell with a single polar
flagellum and a nonmotile cell displaying an adhesive stalk.
Swarmer cells can be isolated by density centrifugation to pro-
duce synchronized cultures that move through the cell cycle in
unison. Swarmer cells differentiate into stalked cells by ejecting
their flagellum and subsequently grow a stalk from the same
cell pole. Chromosome replication is suppressed in the
swarmer cell but initiates upon transition to the stalked form.
Synthesis of the new flagellum at the cell pole opposite the
stalk depends on ongoing DNA replication. Classical and mo-
lecular genetic approaches have generated considerable insight
into gene function and regulation during Caulobacter develop-
ment. For example, the isolation of nonmotile mutants led to
the eventual identification of over 40 genes involved in flagel-
lum synthesis and regulation (6, 13). Further genetic analysis
uncovered complex connections between flagellar regulation
and other cell cycle-dependent processes, including DNA
methylation, chromosome replication, and cell division (14, 20,
29).
The first genetic map of the C. crescentus chromosome was
developed using generalized transduction by bacteriophage
Cr30 and RP4-mediated mobilization of chromosomal DNA
(2, 9). Improved versions of the genetic map served as precur-
sors to a physical map of the C. crescentus genome (7, 8) and,
ultimately, the genome sequence (17). The C. crescentus strain
CB15 genome consists of a single circular chromosome
4,016,942 bp in size, with 3,767 predicted protein-coding genes
(17). Less than 10% of these genes had been identified prior to
the genome sequence, and only 54% have been assigned pos-
sible roles based on similarity to genes from other organisms.
Such a high proportion of genes with unknown functions is not
unusual among sequenced genomes and is indicative of the
need for new tools for elucidating gene function.
Transposon-induced null mutations are easy to generate,
and transposon insertion sites can be mapped by a variety of
techniques, but such mutations are not generally useful for
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studying genes involved in critical processes such as the cell
cycle. When it is necessary to work with point mutations re-
sulting in subtle or conditional phenotypes, genetic mapping
becomes more difficult. Gain-of-function mutations, such as
extragenic suppressors that might reveal gene product interac-
tions, are particularly challenging to map. The favored ap-
proach for cloning a C. crescentus gene in which a non-trans-
poson-induced mutation resides has been to isolate a
complementing cosmid clone from a library of wild-type DNA,
followed by the subcloning and sequencing of the complement-
ing gene. Unfortunately, the cosmid complementation ap-
proach sometimes fails, due to incomplete representation of
the genome in available libraries, or because the mutation in
question has a dominant phenotype.
Although a C. crescentus linkage map containing more than
170 genes with identifiable mutant phenotypes has been devel-
oped (http://www.cosm.sc.edu/caulobacter), the application of
transductional mapping to the study of new mutants has de-
clined in recent years. Establishing transductional linkage of a
mutation to a known gene often did not help much for cloning
the gene in which the mutation resided, unless the linked gene
was present on a known cosmid that might contain the new
gene as well. With knowledge of the complete genome se-
quence, the utility of transductional linkage can be dramati-
cally improved. We reasoned that transductional mapping in C.
crescentus could be made both easier and more efficient if
certain criteria were met. The genomic locations of markers
used for genetic mapping should be known precisely, and the
markers must be distributed around the genome so as to en-
sure complete coverage by transduction. The data obtained in
mapping experiments using these markers should be readily
convertible into a physical location in the genome. The mark-
ers should have selectable phenotypes that do not overlap with
those of frequent interest in C. crescentus, such as progression
of the cell cycle, cell division, or motility. And finally, the
mapping strains containing these genetic markers should be
readily available to all researchers. To this end, we developed
a set of C. crescentus strains containing a kanamycin resistance
gene placed at 100-kb intervals along the genome. Cr30
transduces up to 120 kb of chromosomal DNA at detectable
frequencies, so a mutation located anywhere in the C. crescen-
tus genome should be transductionally linked to at least two
markers in this collection. We demonstrate here the applica-
tion of this mapping approach.
MATERIALS AND METHODS
Bacterial strains and media. C. crescentus and Escherichia coli strains isolated
or constructed by others are listed in Table 1. Strains made during the course of
this work are listed in Table 2. C. crescentus strains were routinely grown in PYE
broth or agar (5) supplemented with antibiotics as necessary: kanamycin (20
g/ml in agar, 5 g/ml in broth), oxytetracycline (2 g/ml in agar, 1 g/ml in
broth), ampicillin (50 g/ml in agar), and nalidixic acid (20 g/ml in agar).
Selection for prototrophy was done on M2 minimal salts medium (5) containing
glucose (0.2%). E. coli strains were grown in Luria-Bertani (LB) broth or agar
(22) supplemented with antibiotics as necessary: kanamycin (50 g/ml), oxytet-
racycline (10 g/ml), or ampicillin (50 g/ml).
Amplification and cloning of DNA segments for marker integration. Marker sites
were chosen at approximately 100-kb intervals along the C. crescentus chromo-
some. The genome sequence, annotation, and numbering were as described by
Nierman et al. (17). The genome sequence and annotation are available online
(www.ncbi.nlm.nih.gov/cgi-bin/Entrez/framik?dbGenome&gi177). In order
to minimize the risk of generating a detectable phenotype other than antibiotic
resistance in any marker strain, the marker locations were chosen so that plasmid
integration in each strain would not disrupt the function of any gene, regardless
of whether the function of the gene was known. To accomplish this, the DNA
TABLE 1. Caulobacter crescentus strains used in this worka
Strain Relevant genotype Description
CB15 Wild-type C. crescentus
CB15N
(NA1000)
Synchronizable derivative of CB15 lacking functional holdfasts
SC111 CB15 metA101 Methionine auxotroph, mutation probably in CC2238 (homolog of E. coli metZ) at 2.438 Mb
SC117 CB15 ilvB101 Isoleucine/leucine auxotroph, mutation probably in CC2100 or CC2101 (acetolactate synthase
subunits) at 2.311 Mb
SC121 CB15 hisB101 Histidine auxotroph, mutation probably in CC2223 (homolog of E. coli hisC) at 2.425 Mb
SC141 CB15 metD104 Methionine auxotroph, mutation in CC2140 (homolog of E. coli metF) at 2.347 Mb
SC268 CB15 motA102 Nonmotile, mutation in motA gene (CC0750) at 0.825 Mb
SC286 CB15 motB108 Nonmotile, mutation in motB gene (CC1573) at 1.739 Mb
SC375 CB15 metB112 Methionine auxotroph, mutation probably in same gene as metA101 (CC2238, a homolog of E. coli
metZ, located at 2.438 Mb)
SC415 CB15 cysE103 Cysteine auxotroph, mutation probably in CC1596 to CC1598 (sulfate transporter subunits
homologous to E. coli cysTWA) at 1.765 Mb
SC420 CB15 aroF110 Aromatic amino acid auxotroph, mutation probably in CC1882 (homolog of E. coli aroD) at 2.078 Mb
SC596 CB15 ts104 No growth at 30°C or higher
SC1612 CB15 ts123 No growth at 37°C
SC1615 CB15 ts129 No growth at 37°C
SC1621 CB15 ts136 Very slow growth at 37°C
SC1622 CB15 ts137 No growth at 37°C
SC1623 CB15 ts138 No growth at 37°C
SC1624 CB15 ts139 No growth at 37°C
SC1625 CB15 ts141 No growth at 37°C
LS107
(MRKA208)
CB15N bla6 Amps Kans derivative of SC1107
UJ195 CB15N pleD::spec Specr and hypermotile (large swarms) due to omega cassette insertion in pleD (CC2462) at 2.669 Mbb
a Most of the mutant strains were described previously by Johnson and Ely (12, 13). Strain UJ195 was described by Aldridge and Jenal (1).
b Spec, spectinomycin.
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TABLE 2. C. crescentus marker strains
C. crescentus
marker strain
Genome sequence coordinates of
targeting fragment (overlapped ORFs) PCR primers for targeting fragment
a
CMS0 41328–42339 (CC0039–0041) For: CGGCGTGGGCGGTGGAGGATGT
Rev: CGGCGTTCGGTGGGCTGGCTGT
CMS1 135832–137201 (CC0126–0128) For: GCGTTTTTCCAGCCGGCCCACAG
Rev: CCTCGCGGCGCCTTTTTCGTTGG
CMS2 239808–240826 (CC0222–0224) For: GGCCAGCATGACCCTTCGACCG
Rev: CGCCGAGTACAAGCCGACCCCGAC
CMS3 339032–340124 (CC0323–0324) For: CGGTGTCGGGTCTGGCGTTCG
Rev: GCGCGCCGGTGCAGCTGTTCTTCT
CMS4 438585–440195 (CC0424–0426) For: CCAGCAGGCGGCGGTCGATTTGAT
Rev: GCGGCGCGTCCAGAAGCTCACT
CMS5 538835–539841 (CC0512–0513) For: CCGGCGGCGCTTTCGTCTTC
Rev: CCGCGTGGAGGAAAAAATCAGGGG
CMS6 638934–640056 (CC0584–0585) For: GCGCGCGATCACCCCACAGAC
Rev: TGGGCCGCGAAGATCCTGAACAAG
CMS7 741557–742473 (CC0674) For: CGTCGATCAGGTGCAGGCCCCAGT
Rev: GGCGGACGGCAAGACCTCGGT
CMS8 845796–846815 (CC0768–0770) For: CGCGCATGAAGGGGCAGGACCAG
Rev: CGGCTTCACCTCGGGGCGGATCC
CMS9 939587–940578 (CC0843–0844) For: GCGGGTGCTGTCCAGTTTCGTCGA
Rev: CCCATGGCCAGCAGGTCGTCGGTGTC
CMS10 1041014–1042197 (CC0937–0939) For: GGCAAGCCGCGCACCATCCTGAT
Rev: GGCGTGCGCAAGGGTCCGGTCATC
CMS11 1060341–1061762 (CC0955–0957) For: CAGCCTGGAAACGGTGATGTCGAT
Rev: CGCCGAACTGTTGCCCGAGCTC
CMS12 1159257–1160692 (CC1029–1030) For: CCCCCCCAAGCCGATGCCGATGAC
Rev: CCGCCCCACCTGGTTCCGCCTCTC
CMS13 1256079–1257163 (CC1107–1108) For: CGGTGGGTCTCGCCTTGGATCGG
Rev: GCGGCAGGCGGTCCAGCAGCAC
CMS14 1349674–1350629 (CC1189–1190) For: GGCCGTGAGAGCGAGCGATGGG
Rev: GCAGCCCGTCCAGCATCACCCTCAT
CMS15 1462150–1462957 (CC1313–1314) For: CCGCGGCCCTCACGACATCCAGAT
Rev: TCGCGACCGTCACCAAGGCCACAG
CMS16 1559310–1560349 (CC1411–1412) For: CGCCCGAGATGAGTTGCCGCTGG
Rev: CGGCTCAGCGCGTCGGAACCCATA
CMS17 1655260–1656305 (CC1496–1497) For: GGGTCACTCGGCCGCCTCGCAGAT
Rev: GGGGAAGAGGCAGGCGCGGTAGGA
CMS18 1750316–1751345 (CC1583–1585) For: CGGCCCAAGGTGCGCGTGATCG
Rev: CGCGGGCGATGGCTTCCTGGC
CMS19 1855379–1856549 (CC1681–1683) For: GCCGCCGCGACCTTGCCTAAA
Rev: CGGGATGTGCGCGGTCTCGTCG
CMS20 1958583–1959461 (CC1774–1775) For: TCGCCTATTTCGTCGCCACCCTG
Rev: GCGGCCTTGTCCACGTGCGTCTC
CMS21 2049425–2050600 (CC1853–1855) For: CGGCGCAAGGATGGACATTCAGGACG
Rev: CGGGCGGCGATGGTCTTGGTGGTC
CMS22 2153536–2154397 (CC1958) For: CCGCCGCCTCAACCCGTCTCGATC
Rev: CGCAAGCGGGGCAGGAGGGAAG
CMS23 2249405–2250489 (CC2043–2044) For: GCGCGACAGCAAGAGCAAGCAGACC
Rev: TCCGGGCGCAGCGAACCTTCT
CMS24 2353191–2354153 (CC2148–2149) For: TGGCGTCGTTGGGCGGGCAGC
Rev: CGCCGGGCAGCATGTCGATCG
CMS25 2453131–2453919 (CC2256–2257) For: CCATCCTCGGCCAGCACGTCCT
Rev: GCCAGCCCGCCGATCCCAACTT
CMS26 2556531–2557393 (CC2356–2357) For: CGTCGAGGCCGGTGTTGGTCTG
Rev: GCGCCGCCTACATCGTCGAGAAG
CMS27 2670146–2670849 (CC2463–2464) For: GCTCTAGAGGTGACCTCCAGACCCGAGA
Rev: GGAATTCAAGCCGTGGGTCTTCAACC
CMS28 2742248–2743137 (CC2537–2538) For: AGCGGCGCGAGCGGATGGTTTTTC
Rev: GCGCGAGGCCACAAGTTGCATCAG
CMS29 2854644–2856043 (CC2637–2638) For: CGCGGCGTGACGGACCTGTTCTTC
Rev: CCGGGCGGGGTGGCGTTCTTG
CMS30 2950035–2951477 (CC2734) For: GCCCATCCCCGTGCGCAACATCAG
Rev: CGCATCGCCGCCAGCCTAGGAACT
CMS31 3055926–3057204 (CC2830–2832) For: GGCGGGCGTGCAGGTCGAAGG
Rev: GGCGTCGAGGGTCTGGGCGTCA
CMS32 3158908–3159721 (CC2935) For: GCGTGCTGCTGACCGGCCTCGT
Rev: CGCAAGCGGGGCAGGAGGGAAG
Continued on following page
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fragments (“targeting fragments”) used to direct integration of the marker plas-
mids were not wholly contained within any gene or operon, including the pre-
sumptive promoter region, which we operationally defined as the 100 bp up-
stream of the start codon. As no algorithm for identifying operons has been
applied to the C. crescentus genome, operons were tentatively identified as sets
of closely spaced genes (often with overlapping stop and start codons) arranged
in the same orientation and usually containing at least two members predicted to
function in the same cellular process.
Once the target site was chosen, primers for PCR were selected using the
GeneTools software package (BioTools Inc., Edmonton, Alberta, Canada).
Primer sequences and locations are shown in Table 2. Primers were synthesized
by Operon Technologies (Alameda, Calif.). All primers were 20 to 24 nucleotides
in length, with the melting temperature (Tm) estimated to be in the range of 68
to 73°C. PCRs had the following composition: each primer at 1 M, 10 ng of
CB15N chromosomal DNA, 250 M deoxynucleotide triphosphates, 5% di-
methyl sulfoxide (DMSO), 2.5 mM MgCl2, and 1 U of Taq DNA polymerase
(Sigma Chemicals, St. Louis, Mo.). Chromosomal DNA was prepared using the
DNEasy kit (Qiagen) according to the manufacturer’s instructions. Amplification
was done with a thermal cycling regimen as follows: (i) 94°C for 1 min, (ii) 30
cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min, and (iii) 72°C for 10 min.
Reaction products were examined by agarose gel electrophoresis. Of the 41
initial targeting fragments selected, 39 were successfully amplified under these
conditions and showed few or no additional nonspecific fragments upon electro-
phoresis. Modification of magnesium and/or DMSO concentration or annealing
temperature allowed the remaining two targeting fragments to be amplified.
PCR products were cloned into the pCR2.1 plasmid vector of the Topo
Cloning System (Invitrogen Corp., Carlsbad, Calif.) according to the manufac-
turer’s instructions. Plasmid DNA was purified from colonies that appeared
white on LB agar plates containing X-Gal (5-bromo-4-chloro-3-indolyl--D-ga-
lactopyranoside), IPTG (isopropyl--D-thiogalactopyranoside), and kanamycin.
The presence of inserts was verified by restriction digestion. The identity and
orientation of inserts was confirmed by cycle sequencing using flanking primers.
Sequencing reactions used the BigDye dideoxyterminator kit (Applied Biosys-
tems, Foster City, Calif.), and reaction products were analyzed on an ABI 310
instrument. Sequence analysis was done with ABI and GeneTools software
(BioTools).
Integration of markers into C. crescentus genome. Targeting fragments were
subcloned into the pBGS18T plasmid vector (Kanr), a derivative of pBGS18 that
contains the RK2 origin of transfer (oriT) (24, 27). Subcloning of the targeting
fragment in most cases was done using the flanking EcoRI sites of the pCR2.1
vector, except where EcoRI restriction sites were present in the amplified seg-
ment, in which case alternative restriction sites were used. E. coli strain S17.1 was
used as a host for the pBGS18T clones. These plasmids were transferred into C.
crescentus CB15N by conjugation, with selection on PYE plates containing kana-
mycin and nalidixic acid for counterselection against the E. coli donor. Plasmid
pBGS18T does not replicate in C. crescentus and thus acts as a suicide vector.
The presence of integrated plasmid DNA was verified by PCR. Genomic DNA
was isolated from each marker strain, and PCR was performed using combina-
tions of one of the primers initially used to amplify the targeting fragment and
one vector-directed primer. When appropriate mutant strains were available, the
chromosomal location of the integrated plasmid was verified by cotransduction
with genes known to be in the vicinity of the target site.
Phage transduction. Plate lysates of Cr30 were prepared by infecting 0.1 ml
of a saturated PYE culture of each Caulobacter marker strain (CMS) with Cr30
at a multiplicity of infection of approximately 1. Infected cells were incubated at
30°C for 15 min and then mixed with 5 ml of molten PYE top agar (0.3% agar)
and poured on a prewarmed PYE plate. After overnight incubation, top agar was
scraped off each plate and suspended in 5 ml of PYE. Chloroform (0.1 ml) was
added to inactivate viable cells from the donor strain, and the lysate was vortexed
vigorously. Lysates were incubated at 4°C for at least 2 h, then vortexed again,
and centrifuged for 10 min at 3,400  g. The supernatant was transferred to a
sterile petri dish and subjected to UV irradiation in a UV cross-linker (Hoefer
model UVC 1000) at a dose of 100,000 J of total energy/cm2. This treatment
typically reduced the phage titer (PFU/milliliter) approximately 1,000-fold and
was found empirically to result in the largest number of transductant colonies.
Lysates were stored at 4°C until use.
Transductions were done by mixing 25 l of UV-treated phage lysate with 475
l of PYE broth and 0.5 ml of saturated PYE culture of the intended C.
crescentus recipient strain. The infected culture was shaken at 30°C for 1 to 4 h.
(The yield of transductant colonies did not appear to vary significantly over this
range of incubation times.) Infected cultures were pelleted by centrifugation and
resuspended in a small volume of PYE for plating. Cells were spread on PYE
agar containing kanamycin, except when a separate phenotype such as nutri-
tional prototrophy was being selected for. Plates were incubated at generally
incubated at 30°C, except in the case of temperature-sensitive (ts) mutant strains,
in which case incubation was at either 25°C (permissive condition) or 37°C
(nonpermissive condition selective for wild-type growth).
The method by which cotransduction rates were determined depended on the
recipient strain. In all cases, Kanr was the initial selected phenotype. Restoration
of prototrophy to auxotrophic mutants was scored by patching Kanr transduc-
tants onto M2/glucose agar. Motility was scored by stabbing transductants into
PYE swarm agar (0.3%). Loss of temperature sensitivity was measured by patch-
ing onto PYE agar and incubating at 37°C. The pleD mutant strain UJ195 (1) was
screened for the loss of spectinomycin resistance. At least 100 colonies were
tested for each strain in determining the reported cotransduction frequencies.
Transcomplementation analysis of mutants. After transduction experiments
had identified the region of the genome in which a particular mutation resides,
candidate wild-type genes were amplified by PCR for complementation testing,
using wild-type CB15N DNA as a template. For LS107 (Amps), the -lactamase
homolog CC2139 (blaA) at bp 2345897 to 2346766 was amplified as a PCR
product starting 191 bp 5 to the coding region and ending 87 bp 3 to the coding
region. Because blaA is suspected to be part of an operon, a series of additional
PCR products were generated that all started 237 bp upstream of CC2141, the
first gene in the putative operon, and progressively added each gene in the
operon (CC2141 to 2137) (see Fig. 3). For temperature-sensitive strain SC1621,
seven PCR products were amplified from the chromosomal region around bp
TABLE 2—Continued
C. crescentus
marker strain
Genome sequence coordinates of
targeting fragment (overlapped ORFs) PCR primers for targeting fragment
a
CMS33 3256387–3257298 (CC3039–3040) For: GGACCCACGACCCCCGCATCAAG
Rev: GCCCCGGCAGGTGGTGGTGAAGAC
CMS34 3360219–3361164 (CC3123–3125) For: GGGGTCTCGCCGGGCCTGTTGC
Rev: GCTGGCGGATGTTTCGGTGCTGAC
CMS35 3458380–3459584 (CC3203–3204) For: GCGGTGTAGCGTGATGGGGGGATG
Rev: CGGCGAACAGCGGCGACAGGAA
CMS36 3556866–3558327 (CC3307–3308) For: CCGCCCCTGTCCGCCATCCA
Rev: GGGGCGCCATCCTGCTCGACAC
CMS37 3653651–3655404 (CC3411–3413) For: CGCGGCTCTCTGACGGTCGATGA
Rev: CGCCTCGGTGGTGTCGTTCATGA
CMS38 3754553–3755968 (CC3510–3511) For: CCTGCTGCGCCTGAACGACGAGAT
Rev: CTGCGTCGCCTGCTGTCGGTGGT
CMS39 3855274–3856437 (CC3601–3603) For: CCCGCGCCCGACAGGATCAAC
Rev: GGCGCTGCTGACGAATCCGAAGG
CMS40 3950897–3952188 (CC3699–3700) For: GCCGTGCGCGCCAATCTCGAC
Rev: GCGGCTACTTCAAGGGCGGGCTC
a For, forward; Rev, reverse.
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1180000 to 1200000, ranging in size from 2 to 6 kb. Product 1 contained CC1043
and CC1044 (phenylalanyl-tRNA synthetase subunits). Product 2 contained
CC1045 and CC1046 (ribosomal subunits L20 and L35). Product 3 contained
CC1049 to CC1052. Product 4 contained CC1053 to CC1055 and the two adja-
cent glycine tRNA genes. Product 5 also contained the glycine tRNA genes, plus
CC1056 to CC1059. Product 6 contained CC1061 to CC1063. Product 7 con-
tained CC1070 (peptide chain release factor 3). PCR was done with Accutaq
Long-read Taq polymerase (Sigma Chemical Co.) and the supplied reaction
buffer, plus 2% DMSO, and then cloned into plasmid pCR2.1 by using the Topo
Cloning System (Invitrogen). The amplified fragments were subcloned into plas-
mid pMR20 in the E. coli S17.1 host and introduced into mutant strains by
conjugation. Conjugants were selected on PYE containing tetracycline and na-
lidixic acid. For LS107, complementation was tested by streaking on PYE agar
containing 50 g of ampicillin/ml. For SC1621, complementation was tested by
streaking on PYE agar containing tetracycline and incubating at 37°C. The
CC1061 and CC1062 genes were subsequently amplified individually using prim-
ers flanking the coding regions, allowing at least 100 bp upstream of each for
possible promoter sequences. The PCR products were cloned initially into
pCR2.1 and then subcloned into pMR10 (Kanr). (Attempts to clone the products
into pMR20 were unsuccessful.) As with pMR20, E. coli S17.1 was used as the
cloning host, and plasmids containing inserts were transferred into SC1621 by
conjugation. The same flanking primers were used to amplify CC1061 from
SC1621 chromosomal DNA. The 0.6-kb PCR product was cloned into the
pCR2.1 vector for sequencing.
Construction of blaA strain. The wild-type blaA gene contains a SacI restric-
tion site at bp 832 to 837, near the 3 end of the coding region. To construct a
deletion of the blaA coding region, PCR-mediated site-directed mutagenesis was
used to introduce a new SacI restriction site at bases 72 to 77 of the coding
region. A pair of complementary primers was synthesized (BlaSacFor [ACGTC
GTCCGAGCTCCATGTGGTG] and BlaSacRev [CACCACATGGAGCTCGG
ACGACGT]) containing the two-base change (GG to CT at bp 75 and 76)
necessary to generate the SacI site. These primers were used in separate ampli-
fication reactions with primers located in the upstream (metF) and downstream
(metH) genes. The PCR products were isolated and combined together in a
second amplification reaction to generate the complete blaA coding region con-
taining the additional SacI site. The mutant gene was subcloned into the
pNPTS138 vector, which has no SacI sites. pNPTS138 is a 5.4-kb Kanr plasmid
that contains the counterselectable sacB gene, encoding levansucrase (21;
M. R. K. Alley, personal communication). Once in pNPTS138, the 760-bp SacI
fragment was removed, deleting 90% of the blaA coding region but retaining a
continuous open reading frame (ORF) across the deletion to avoid potential
polar effects. pNPTS138 was introduced into C. crescentus CB15N by conjuga-
tion, with integrants selected for on PYE agar containing kanamycin. Several
colonies containing the integrated plasmid were then grown to saturation in PYE
broth under nonselective conditions (no antibiotics) and plated on PYE agar
containing 3% sucrose to select for plasmid excision. Sucrose-resistant colonies
were scored for resistance to kanamycin and ampicillin. Of the kanamycin-
sensitive isolates (i.e., those in which most or all of the plasmid was deleted from
the chromosome), approximately one-third were also sensitive to ampicillin,
suggesting that the blaA gene containing the internal deletion remained. Chro-
mosomal DNA was prepared from four such isolates, and PCR analysis verified
the presence of an internal deletion in the sole copy of blaA.
RESULTS
Construction of marker strain collection. A major goal of
this project was to develop a set of C. crescentus strains con-
taining genetic markers whose location in the genome se-
quence is precisely known. The main factor in deciding how to
position Kanr markers was to ensure that every chromosomal
gene would be within a transducible distance from a marker.
To determine how much chromosomal DNA bacteriophage
Cr30 can transfer, published transduction data was reexam-
ined by using the genome sequence to determine the actual
sequence lengths separating loci that can be cotransduced.
Examples of such data are the argG locus (arginosuccinate
synthase; CC0129, bp 137246 to 138472) and the leuA locus (an
operon encoding 3-isopropylmalate dehydratase [CC0193] and
3-isopropylmalate dehydrogenase [CC0194], bp 206989 to
210531), which are separated by approximately 70 kb and were
reported to cotransduce at a frequency of 8 to 26% (according
to Barrett et al. [2]). The hisD locus (histidinol dehydrogenase;
CC2346, 2545970 bp) and the argA locus (an operon encoding
ornithine carbamoyltransferase [CC2242] and acetylornithine
aminotransferase [CC2243], bp 2443239 to 2440969) are sep-
arated by 105 kb and cotransduce at a rate of 2% (2). Based on
the published data and personal communications from other
investigators, it appears that the transducing capacity of bac-
teriophage Cr30 is limited to 120 to 150 kb of chromosomal
DNA. In light of this, we chose to integrate markers at approx-
imately 100-kb intervals, so that any gene on the chromosome
could theoretically be cotransduced with at least two markers.
A collection of 41 CMS strains was constructed (Table 2 and
Fig. 1). The Kanr markers were inserted at the desired chro-
mosomal locations by using PCR to amplify a small targeting
fragment (0.8 to 1.7 kb) representing the insertion site and
cloning the targeting fragment into a suicide vector
(pBGS18T) to direct integration via homologous recombina-
tion. Insertion sites were chosen to minimize the possibility of
gene disruption (see Materials and Methods). Integration of
the marker plasmids was obtained following conjugal transfer
from the E. coli cloning host to C. crescentus CB15N. Inte-
grants were selected on PYE agar containing kanamycin. The
integrated plasmids appear to be stable. Three randomly cho-
sen CMS strains were grown for at least 10 generations in PYE
broth lacking kanamycin and then were plated on PYE agar
with no antibiotic. In all three cases, all 100 of the colonies
tested retained kanamycin resistance, suggesting that plasmid
excision and loss under nonselective conditions occurs at a rate
significantly less than 1% per generation. Excised recircular-
ized plasmid DNA can be detected by PCR in DNA prepara-
tions from these strains (data not shown), but its occurrence
appears to have no impact on use of the strains for genetic
mapping.
It is important that the marker strains are free of additional
phenotypes resulting from plasmid integration, as other non-
wild-type properties could interfere with the use of a strain in
mapping certain mutations. All strains were examined micro-
scopically for obvious morphological defects, but none were
observed. The growth of each strain in PYE broth cultures was
assayed by monitoring optical density. The resulting growth
curves were very similar to control cultures of the parental
wild-type strain CB15N (data not shown).
The marker strains all produce plaques at similar efficiencies
when infected with Cr30, and produced lysates of similar
titers (PFU/milliliter) (data not shown). However, some dif-
ferences were observed in the numbers of Kanr colonies ob-
tained in transduction experiments using identically prepared
Cr30 lysates from each donor strain, with CB15N as the
recipient. For most of the markers, the number of Kanr colo-
nies obtained varied over a two- to threefold range from
marker to marker and from experiment to experiment. The
exception was that lysates prepared from strains containing
markers integrated in the chromosomal region between 3.2
and 3.7 Mb consistently yielded only 1 to 10% of the number
of Kanr colonies typically obtained with markers outside this
region.
Testing the marker strain collection. The mapping system
was tested with 12 strains containing mutations whose approx-
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imate chromosomal locations are known (Table 1 and Fig. 1)
(12). These strains, which served as recipients for transduc-
tions, were primarily auxotrophs and motility mutants. In some
cases, the mutation in the test strain had been experimentally
shown to reside in a specific gene. In other cases, the mutation
had been mapped relative to other loci, but inspection of the
genome sequence in the predicted region (Fig. 1) revealed a
strong candidate gene. Cr30 plate lysates were prepared from
each Kanr donor strain. Mutant recipient strains were then
infected, with selection for Kanr on PYE agar. Transductants
were screened for the absence of the mutant phenotype. In all
cases, linkage to markers near the previously mapped location
was observed. No cotransduction was observed (among the 100
to 200 colonies tested in each experiment) when the distance
between sites was 130 kb or greater, suggesting this was a
practical upper limit for Cr30. The results of many test trans-
ductions are compiled in Fig. 2. Cotransduction frequency
declined logarithmically as the sequence length separating the
marker and the mutant gene increased (Fig. 2A and B). A plot
of log(distance) as a function of cotransduction frequency pro-
duced a linear regression as described by the following equa-
tion: log(distance)  	1.56(CTF)  5.06, where CTF is co-
transduction frequency. The high correlation coefficient (R2 
0.903) of the linear regression is indicative of the strong asso-
FIG. 1. Correlation of genetic and sequence-based maps of C. crescentus and locations of antibiotic resistance markers. The hashmarks and
numerical labeling on the inside of the circle indicate genetic map coordinates, as reported by Ely (http://www.cosm.sc.edu/caulobacter/map.html).
The hashmarks and numerical labeling on the outside of the circle indicate DNA sequence coordinates, based on the GenBank-deposited genome
sequence and annotation (17). The genome sequence numbering starts at the origin of replication, located at 1830 on the genetic map, and
proceeds in the direction opposite that of the genetic map coordinates. Representative loci shown on both the inside and the outside have been
mapped genetically and can be associated with specific genes or operons in the DNA sequence with a high degree of confidence. “Lollipops” on
the outer circle indicate the locations of Kanr integrated plasmid markers in CMS strains, as described in the text and Table 2. Mutations in the
genes indicated in bold were used for the cotransduction frequency analysis. The approximate locations of mutations resulting in temperature-
sensitive growth are shown on the outer circle.
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ciation between the CTF and log(distance) variables. This
equation should be useful for estimating distances from Cr30
cotransduction data in future work.
Mapping ampicillin sensitivity. Wild-type C. crescentus is
resistant to ampicillin (MIC, 100 g/ml in PYE broth). The C.
crescentus genome sequence contains nine ORFs with homol-
ogy to the -lactamase superfamily distributed throughout the
genome. Despite this multiplicity of -lactamase homologs,
Barrett et al. (2) isolated strain SC1107 as an ampicillin-sen-
sitive Tn5-induced mutant, suggesting that a single gene is
responsible for high-level ampicillin resistance. The amp locus
is transductionally linked to the metD and ilvB loci (2). Based
on the alignment in Fig. 1, the amp locus is in the 2.3- to
2.4-Mb region of the genome (Fig. 1). An Amps Kans deriva-
tive of SC1107 (LS107) in which the Tn5 was thought to have
been excised (27) was used to map the amp mutation relative
to the CMS markers. LS107 was infected with Cr30 lysates
derived from each of the marker strains. Only the marker at
2.35 Mb in CMS24 was tightly linked to Ampr, with an 85%
cotransduction rate.
Inspection of genes near the CMS24 marker showed a -lac-
tamase homolog 8 kb away (ORF CC2139 at bp 2345897 to
2346766). The CC2139 product is a 289-amino-acid polypep-
tide related to the Stenotrophomonas maltophilia L1 metallo-
-lactamase (Fig. 3a). Several lines of evidence support the
identification of this gene, for which we suggest the designation
blaA, as responsible for ampicillin resistance in C. crescentus.
PCR analysis using primers positioned both upstream from
and within the blaA coding region demonstrated the presence
of a 2-kb insertion in LS107 near the 5 side of the coding
region. Sequence analysis of a PCR product generated from
LS107 showed that a remnant of the original Tn5 is inserted at
codon 31 of blaA. The wild-type blaA gene, amplified from
CB15N and cloned into the pMR20 plasmid vector, was suffi-
cient to restore ampicillin resistance to LS107. The chromo-
somal context of the blaA gene suggests that it is part of an
operon containing at least three other genes. The blaA start
codon overlaps the stop codon of the preceding ORF
(CC2140), and its stop codon overlaps the start codon of the
subsequent ORF (CC2138) (Fig. 3b). A PCR product contain-
ing the upstream genes of the putative operon and the inter-
genic region expected to contain the operon promoter was also
cloned into pMR20. When introduced into LS107, this con-
struct produced colonies that grew more rapidly and to larger
size in the presence of ampicillin than the pMR20 construct
containing only the region immediately surrounding blaA.
An ampicillin-sensitive strain of C. crescentus could be useful
for various genetic applications, including the use of ampicil-
lin-resistant plasmid vectors. SC1107 is not an ideal strain for
such applications, as it is in the nonsynchronizable CB15 back-
ground and it is also Kanr. LS107 is Kans and synchronizable,
but it shows some anomalous behavior, including low conjuga-
tion efficiency and poor growth on M2G minimal medium (C.
Stephens, unpublished observations). The growth phenotype
may result from a polar effect of the Tn5 remnant on expres-
sion of the metH gene (see below). We therefore constructed
an in-frame deletion of nearly 90% of the blaA coding se-
quence (codons 59 to 279) and exchanged it with the wild-type
locus to generate strain CS606. This deletion results in sensi-
tivity to ampicillin (MIC, 1 g/ml) comparable to that of LS107
(MIC, 0.5 g/ml). CS606 is morphologically indistinguishable
from CB15N and is superior to LS107 in that it is wild type with
respect to growth on minimal media and as a recipient for
conjugal transfer of plasmid DNA (data not shown).
FIG. 2. Cotransduction frequency as a function of distance from marker. Data were derived from transduction experiments by using combi-
nations of 12 different mutant strains (noted in Fig. 1 and Table 1) and 19 different CMS markers. Cotransduction frequency was calculated as the
number of transductants in which the wild-type version of a gene being tested was transferred along with Kanr marker divided by the total number
of Kanr transductants tested. (A) Plot of cotransduction frequency as a function of the distance separating the marker and test gene. Distances
were corrected for the length of plasmid DNA between insertion site and the kanamycin resistance gene (
1 or 3 kb, depending on orientation
of intergrated plasmid). (B) Plot of log(distance) as a function of cotransduction frequency. The linear regression is described by the following
equation: log(distance)  	1.56(CTF)  5.06, with R2  0.903.
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Of the other genes in the putative blaA operon, at least two
are predicted to be involved in methionine synthesis. The gene
immediately 5 to blaA (CC2140) is homologous to the E. coli
metF gene, encoding 5,10-methylenetetrahydrofolate reduc-
tase, while the gene immediately 3 to blaA (CC2138) is ho-
mologous to the 5 portion of the E. coli metH gene, encoding
the N-terminal domain of 5-methyltetrahydrofolate-homocys-
teine methyltransferase. Application of the transductional
mapping method to C. crescentus strain SC141, a methionine
auxotroph with a mutation at a locus designated metD, indi-
cated that the metD gene is also closely linked to the CMS24
marker (53% cotransduction). The plasmids constructed for
mapping amp were tested for complementation of SC141. The
results indicated that the metF homolog (CC2140) was neces-
sary to complement the SC141 auxotrophy, suggesting that the
mutation in SC141 resides in this gene (Fig. 3).
Mapping mutations responsible for temperature-sensitive
growth. Johnson and Ely (12) isolated a number of spontane-
ous mutant strains exhibiting temperature-sensitive growth.
Such mutations are generally thought to be indicative of genes
involved in critical cellular processes. Transductional mapping
with the CMS marker collection was used to localize several of
these ts mutations. Mutant strains were infected with Cr30
lysates prepared from the marker strains and spread on PYE/
Kan agar. For each marker, one infection plate was incubated
at room temperature (
24°C) and one at 37°C. Any 37°C
plates that produced Kanr colonies indicated that the marker
in that donor strain was linked to the wild-type version of the
desired mutant gene. Transductants were then patched from
the corresponding permissive temperature plate onto PYE/
Kan and incubated at 37°C, to determine the frequency of
cotransduction of the wild-type gene with the markers.
C. crescentus strain SC1625 cells grow very slowly at 24 and
30°C, form colonies significantly smaller than CB15N, and do
FIG. 3. Analysis of blaA region. (A) Schematic of the chromosomal region from approximately bp 2349000 to 2343000. CC2141 encodes a
326-amino-acid polypeptide similar to those of the ArsR family of transcriptional regulators. CC2140 encodes a 315-amino-acid polypeptide
homologous to the E. coli 5,10-methylenetetrahydrofolate reductase. CC2139 encodes a 289-amino-acid homologous to L1-type metallo--
lactamases. CC2138 encodes a 359-amino-acid polypeptide homologous to the amino-terminal domain of 5-methyltetrahydrofolate-homocysteine
methyltransferase, while CC2137 encodes a 900-amino-acid polypeptide homologous to the C-terminal domain of the same enzyme. The locations
of the Tn5 remnant in LS107 and the extent of the deletion in CS606 are indicated. Boxes beneath the genes indicate fragments amplified by PCR
and inserted into the pMR20 vector to generate the pCS plasmids indicated. Complementation of LS107 was scored positive () if colonies grew
on PYE agar containing 50 g of ampicillin/ml. Complementation of SC141 was scored positive () if cultures grew to saturation in M2/glucose
broth containing no amino acid supplements. (B) Alignment of the C. crescentus BlaA polypeptide sequence with the S. maltophilia BlaS sequence
(protein identifier g111125376). ∧, known (BlaS) or predicted (BlaA) signal peptide cleavage sites; #, residues known to be involved in zinc
coordination or the reaction mechanism of the BlaS protein (28); , residues that are identical in all five polypeptides; :, chemically similar residues.
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not form colonies at 37°C. The ts141 mutation in SC1625 was
in a gene tightly linked to the marker in strain CMS22 at 2.15
Mb (94% cotransduction) and was weakly linked to the marker
in CMS21 at 2.05 Mb (15% cotransduction). Based on Fig. 2,
the gene was estimated to be located at approximately 2.135 to
2.145 Mb. A large operon or set of operons encoding 15 sub-
units of the NADH dehydrogenase I complex is located at bp
2135337 to 2151496, suggesting that the mutation in SC1625
affects a subunit of this enzyme. C. crescentus is obligately
aerobic, and the small-colony phenotype of this strain is con-
sistent with a mutation causing a defect in respiratory electron
transport. Given the large size of the gene cluster and the likely
organization of the genes into one or a small number of oper-
ons, we did not attempt to define which gene the mutation
resides in by sequencing or complementation.
C. crescentus strain SC1621 forms colonies similar to CB15N
at 24 and 30°C but grows very slowly at 37°C. The ts136 mu-
tation in SC1621 resides in a gene linked to the CMS12 marker
at 1.16 Mb (33% cotransduction) and the CMS13 marker at
1.26 Mb (11% cotransduction). Based on Fig. 2, the gene was
estimated to be located at approximately 1.18 to 1.21 Mb. To
identify the actual gene in which this mutation is located, the
genomic region from 1.173 to 1.203 Mb was divided into seg-
ments containing two to four genes for amplification by PCR.
The PCR products were cloned into plasmid pMR20 and then
introduced into SC1621. Plasmid-bearing strains were grown in
PYE at 37°C to test for complementation. The only plasmid
from this set that allowed growth of SC1621 cells at 37°C
contained a 3.6-kb insert including CC1061 to CC1063 (Fig.
4A). A smaller insert in which the majority of CC1063 (divJ)
was removed also allowed growth at 37°C, suggesting that one
of the two remaining ORFs contained the mutation in strain
SC1621. CC1061 is a small gene starting at bp 1193102 that
encodes a 141-amino-acid polypeptide whose sequence is ho-
mologous to those of ORFs found in diverse bacteria (Fig. 4b)
but whose functions are unknown. CC1062 encodes a sensor
kinase with a high degree of similarity to the adjacent divJ
gene. Although CC1061 and CC1062 are in the same orienta-
tion, the spacing between the coding regions (43 bp) suggests
they do not form an operon. The two wild-type genes were
FIG. 4. (A) Comparison of C. crescentus ORF CC1061 product to homologs from other species. Alignment was done using CLUSTALW (26).
(B) The aligned polypeptides are C. crescentus CC1061 (protein identifier [PID] g16125313), Mesorhizobium loti (PID 14027113), Sinorhizobium
meliloti (PID g7404510), Agrobacterium tumifaciens (PID g15155913), and Pectobacterium (Erwinia) chrysanthemi (PID 11342550). , residues that
are identical in all five polypeptides; :, chemically similar residues. The underlined regions are the predicted membrane-spanning regions. Serine
114, the site of the ts136 mutation in SC1621, is highlighted in bold in the C. crescentus sequence. The mutational change to proline is indicated
above S114.
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amplified separately, but we were unable to subclone them into
pMR20 for unknown reasons. They were, however, success-
fully subcloned into pMR10, a low-copy-number Kanr plasmid
vector. Only CC1061 restored growth to SC1621 at 37°C (Fig.
4a). CC1061 was amplified by PCR from the SC1621 chromo-
some for sequencing, and a single base change (T to C) was
identified that changes the Ser 114 codon (TCC) to a proline
codon (CCC).
Several additional mutations resulting in temperature-sensi-
tive growth were mapped but have not yet been attributed to
individual genes. The ts104 mutation in strain SC596 maps to
the 0.34- to 0.38-Mb region of the genome, consistent with its
previously established linkage to the proA locus (2), which is
suggested by the genome sequence to be the glutamate kinase
gene (CC0314) at 0.331 Mb. The ts123 mutation in strain
SC1612 maps to 0.76 to 0.80 Mb. The ts129 mutation in strain
SC1615 maps to the 2.29- to 2.33-Mb region of the genome.
The ts137 mutation in strain SC1622 maps to the 1.52- to
1.56-Mb region of the genome. The ts138 mutation in strain
SC1623 maps to the 1.85- to 1.89-Mb region of the genome.
The ts139 mutation in strain SC1624 maps to the 1.16- to
1.20-Mb region of the genome, which is very close to the ts136
mutant allele in SC1621. However, none of the plasmid clones
tested for complementation of SC1621 restored growth at 37°C
to SC1624, suggesting that the mutation either is not in one of
the genes tested or is dominant. The ts121 mutation in SC1610
could not be mapped because this strain failed to yield Kanr
transductant colonies even at the permissive temperature, de-
spite being sensitive to infection by Cr30, as indicated by
plaque formation.
DISCUSSION
We have described a method for rapid and efficient genetic
mapping using a collection of markers strategically positioned
in the C. crescentus genome and used this method to localize
several mutations with interesting phenotypes. Linking pheno-
type to genotype is the essence of genetic analysis in any
organism, and tools that allow this connection to be made as
quickly as possible by taking advantage of newly available
genomic DNA sequences will be quite valuable. The C. cres-
centus chromosome is comprised of slightly more than 4 mil-
lion base pairs of DNA and approximately 3,800 genes (17).
The collection of C. crescentus strains described here can be
used to localize a mutant gene to a sequence interval equiva-
lent to less than 1% of the genome. After the initial set of
transducing lysates is made from the donor strains, mapping
any mutation to this level of resolution can be completed in
less than 1 week and multiple mutant strains can easily be
analyzed in parallel. Transductional mapping is also attractive
in that it is inexpensive (particularly since these marker strains
are freely available to research labs working with Caulobacter),
requiring little more than agar plates, centrifuge tubes, and
toothpicks.
The mapping of a mutation resulting in ampicillin sensitivity
demonstrated that ampicillin resistance in wild-type C. crescen-
tus is due to the -lactamase gene (blaA) located at 2.35 Mb in
the genome. The dependence on blaA for high-level resistance
to ampicillin in PYE medium suggests that the remaining eight
-lactamase genes identified in the C. crescentus genome an-
notation either are not expressed under these conditions, en-
code inactive enzymes, or encode enzymes active against -lac-
tams other than ampicillin. Seven of these sequences lack a
functional signal peptide, based on analysis with the SignalP
algorithm (16), and thus may not be exportable to the
periplasm even if expressed. Other than BlaA, only the
CC1540 gene product is predicted to have a functional signal
peptide; whether this product is expressed and contributes to
the residual low-level ampicillin resistance seen in the absence
of blaA in LS107 and CS606 is not known. The blaA gene was
probably acquired by horizontal transfer from another organ-
ism, as the protein sequence is most similar to class B metallo-
-lactamases from four phylogenetically diverse species: S.
maltophilia (Proteobacteria, gamma subdivision) (aligned in
Fig. 4), Fluoribacter gormanii (Proteobacteria, gamma subdivi-
sion), Janthinobacterium lividum (Proteobacteria, beta subdivi-
sion), and Chryseobacterium meningosepticum (Flavibacteria
group). The C. crescentus BlaA sequence contains the critical
zinc coordinating residues and active site aspartate identified
in the S. maltophilia L1 -lactamase crystal structure (28).
Interestingly, despite its apparent acquisition from another
organism, the GC content of the blaA coding region (67%)
and its codon usage pattern are quite typical of C. crescentus
genes. blaA is seamlessly integrated into an operon involved in
methionine synthesis, including homologs of the E. coli metF
and metH genes that overlap the blaA start and stop codons,
respectively.
Mutations resulting in temperature-sensitive growth were
also mapped. One of these mutations (ts141) is likely to affect
NADH dehydrogenase I, a complex enzyme made up of at
least 14 subunits. This integral membrane complex carries out
the initial electron transfer and proton pumping events of
respiratory electron transport, which are critical in an obli-
gately aerobic organism, such as C. crescentus. NADH dehy-
drogenase complex I gene expression and protein levels are
cell cycle-regulated in C. crescentus, suggesting that the enzyme
may be preferentially active in the stalked and predivisional
cells (10, 14). A second mutation causing temperature sensi-
tivity (ts136) resides in a conserved gene whose function is
unknown. The CC1061 product is a 15-kDa polypeptide whose
most notable properties are that it is quite acidic (pI  4.66)
and it is predicted to have a transmembrane domain spanning
residues 80 to 92 (Fig. 4). Homologs of this gene product are
found in related gram-negative proteobacteria from the alpha
subdivision (e.g., Sinorhizobium meliloti and Agrobacterium
tumifaciens) and in more distantly related proteobacteria (e.g.,
E. coli, Yersinia pestis, and Xylella fastidiosa). One of these
homologs (Erwinia chrysanthemi SufE) has been postulated to
have a role in insertion of Fe-S centers in proteins (15). The
mutation in strain SC1621 (Ser114 to Pro) is predicted to
disrupt a conserved  helix in the cytoplasmic domain of the
CC1061 protein. It is not known at this time how this results in
temperature sensitivity. Further experiments to define the role
of this gene product in C. crescentus metabolism and growth
are under way.
Before this work, transductional mapping could be used to
determine the position of a mutation in the C. crescentus ge-
nome relative to other genes (markers) that had been previ-
ously mapped. With the genome sequence now known, data on
cotransduction frequency become much more useful for locat-
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ing a mutation, assuming the precise location of the markers
used for mapping is known. An alignment of the C. crescentus
genetic map and the genome sequence is shown in Fig. 1, with
the positions of the CMS markers indicated. There is generally
good agreement between the genetic map and actual gene
locations derived from the genome sequence. A few discrep-
ancies in gene order are apparent, such as the inversion of the
secA-rpoD-fliI gene order on the genetic map relative to the
actual sequence, and the incorrect order of rrnA, trpB, and
rpoN. Perhaps not coincidentally, both of these problematic
segments occur in or near a region of the genome (3.2 to 3.7
Mb) that is difficult to map genetically.
How well do relative distances determined by genetic anal-
ysis (especially Cr30 transduction) correlate with actual DNA
sequence lengths? This is a critical question, as maximally
effective use of transductional mapping data requires cotrans-
duction frequency data to be reliably convertible into DNA
sequence distances so that the investigator can determine what
section of the genome sequence to focus on. In Fig. 1, distances
between loci on the genetic map compared to the DNA se-
quence are generally consistent, with 1 map unit approximately
equal to 1 kb, but there are regions where genetically deter-
mined distances appear to not match well with sequence dis-
tances, leading to an offset in the two maps. Our own cotrans-
duction data from several markers and mutant strains exhibit a
reasonably consistent mathematical relationship between co-
transduction frequency and distance (Fig. 2), though some
variation is apparent. How much of this is due to experimental
factors versus intrinsic differences between sites on the genome
is not clear, but investigators using this method should be
aware that the relationship between cotransduction frequency
and distance may not be constant for all parts of the genome.
Local variations in recombination probability that affect the
incorporation of transduced or conjugally transferred DNA
into the host chromosome may at least partially explain such
discrepancies. For example, early versions of the C. crescentus
genetic map could not be closed into a circle, as loci at the ends
could not be linked by either transduction or RP4-mediated
chromosome transfer. This was later attributed to an excep-
tionally high frequency of recombination in the region in which
the terminus of replication is predicted to lie (1.8 to 2.0 Mb;
Fig. 1) (7).
Factors unique to transduction can also affect mapping re-
sults. It is not known to what extent Cr30 has cleavage pref-
erences for different DNA sequences or what the distribution
of preferred sites is on the genome. We observed that trans-
ductants containing markers in the chromosomal region from
3.2 to 3.7 Mb are recovered at a much lower rate than markers
elsewhere. Barrett et al. (2) noted this as well and suggested
that it might be due to a low frequency of phage packaging
start sites in this region. Whatever the reason, poor recovery of
transductants makes it more difficult to map genes in this
region, as extra effort is required to recover enough transduc-
tants to accurately assess linkage.
During the course of this work we encountered a few mutant
strains that could not be transduced by Cr30 and were thus
not amenable to this mapping approach. Some strains cannot
be infected by Cr30, as indicated by a lack of plaque forma-
tion on top agar. Such strains may contain mutations affecting
the expression or assembly of the proteinaceous surface array
that serves as the receptor for Cr30 (4). Other strains, such as
SC1610, yield plaques on top agar, indicating that there are no
problems with phage infection, but nevertheless yield no trans-
ductants. Mutations in recA have this phenotype, presumably
because the exchange of incoming DNA fragments with the
host chromosome is blocked (18). Of course, the mutation
responsible for transduction problems in a given strain might
not also cause the original phenotype(s) of interest, as second-
ary mutations causing resistance to Cr30 are not uncommon
(12).
The transductional mapping approach described here avoids
potential problems associated with cosmid complementation.
Dominant mutations are not a problem to map, since the
mutant gene is replaced by a transduced wild-type version.
Furthermore, no region of the genome is left uncovered. With
selectable markers distributed at 100-kb intervals throughout
the genome, no gene can be located farther than 
50 kb from
a marker in at least one of the strains in this collection. De-
pending on the phenotype and location of the mutation being
investigated, other mutant genes (Fig. 1), including many spon-
taneous or Tn5 mutants with easily scored auxotrophies (12),
might be used as additional genetic markers to potentially
increase the resolution of transductional mapping. Transduc-
tional mapping does not, however, eliminate the utility of cos-
mids and smaller plasmids for testing complementation. In-
deed, combining this method with an enhanced cosmid library,
particularly an ordered set of cosmid clones with inserts span-
ning the genome, would further accelerate genetic research.
Using a combined approach, a 20- to 40-kb interval of the
genome identified by transduction to contain a mutation (as-
suming it is recessive) could immediately be tested for comple-
mentation by appropriate cosmid clones to confirm and narrow
the location of the mutation. Efforts to make an ordered set of
cosmid clones spanning the C. crescentus genome, as has re-
cently been done for Pseudomonas aeruginosa (11), are under
way.
A genetic mapping system similar to that described here
could be developed for any bacterium whose genome has been
sequenced and for which a mechanism for chromosomal trans-
fer from one strain to another exists. With respect to marker
production, usable plasmid-contained antibiotic resistance
genes are available for most species. Plasmid pBGS18T is an
especially useful delivery vector, since the RK2 oriT sequence
allows it to be transferred from E. coli into a variety of bacteria,
but it is not necessary to use this plasmid. Any plasmid that can
be forced to stably integrate via a cloned targeting sequence
should be acceptable. With respect to chromosome transfer,
transducing phages have been isolated for many different bac-
terial species; for a recent example, see work by Burke et al.
(3). Other transfer mechanisms could be used to deduce rela-
tive distances from markers. Chromosomal DNA can be trans-
ferred via conjugation, as with E. coli Hfr strains (23) or RP4-
mediated mobilization of the C. crescentus chromosome (2). At
this point, however, it appears that transduction may be the
best approach for genetic mapping in bacteria in conjunction
with a genomic DNA sequence, as phages transfer consistent
lengths of chromosomal DNA between cells, yielding repro-
ducible quantitative results for inferring sequence distances
between genes.
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